The global life science products market is witnessing robust growth due to continuous innovation in biotechnology, diagnostics, and pharmaceutical R&D. The market was valued at USD 3.15 billion in 2024, expected to grow to USD 3.48 billion in 2025, and is projected to reach USD 8.65 billion by 2034, expanding at a CAGR of 10.56% from 2025 to 2034.

Key market drivers include the growing adoption of artificial intelligence (AI) to enhance laboratory workflows, an increase in research collaborations, and a rise in biopharma R&D globally.

---

Market Highlights

• 2024 Market Size: USD 3.15 Billion

• 2034 Projection: USD 8.65 Billion

• Growth Rate (CAGR 2025-2034): 10.56%

• North America Market Share (2024): ~42%

• Fastest-Growing Region: Asia Pacific

• Leading Segment: Reagents & Consumables (~40% share in 2024)

---

Top Companies in the Life Science Products Market

1. Thermo Fisher Scientific

• About: A global leader in scientific instrumentation, reagents, and consumables.

• Products: Brands like Invitrogen, Gibco, and Applied Biosystems offering cell culture, protein analysis, sequencing, and more.

• Market Cap: Approx. USD 200 billion.

2. Merck KGaA (MilliporeSigma in the U.S.)

• About: German multinational offering healthcare, life science, and performance materials.

• Products: Lab chemicals, reagents, bioprocessing equipment, and gene editing tools.

• Market Cap: Approx. USD 80 billion.

3. Danaher Corporation

• About: A science and technology innovator operating various diagnostics and life sciences brands.

• Products: Cytiva, Beckman Coulter Life Sciences, and IDT providing genomics, cell analysis, and diagnostics.

• Market Cap: Approx. USD 175 billion.

4. Agilent Technologies

• About: Specializes in analytical instruments, software, and services for laboratories.

• Products: Genomic and proteomic solutions, lab automation, chromatography, and spectroscopy.

• Market Cap: Approx. USD 35 billion.

5. Bio-Rad Laboratories

• About: Focuses on products for life science research and clinical diagnostics.

• Products: PCR systems, electrophoresis, western blotting, and antibodies.

• Market Cap: Approx. USD 10 billion.

6. Qiagen

• About: A leader in molecular diagnostics and sample-to-insight solutions.

• Products: PCR, sample preparation, NGS, and bioinformatics tools.

• Market Cap: Approx. USD 10 billion.

7. PerkinElmer (Revvity)

• About: Rebranded to Revvity; focuses on lab automation and multi-omics tools.

• Products: Genomics, imaging platforms, and cell-based screening.

• Market Cap: Approx. USD 12 billion.

8. BD Biosciences

• About: A division of Becton, Dickinson and Company; specializes in diagnostics and life sciences.

• Products: Flow cytometry, cell sorters, and clinical research tools.

• Market Cap: Approx. USD 65 billion (parent company).

9. Eppendorf AG

• About: German biotech company offering premium laboratory products.

• Products: Pipettes, centrifuges, bioreactors, and lab plasticware.

• Market Cap: Private company (estimated value around USD 3–5 billion).

10. Promega Corporation

• About: A privately held company offering tools for genomics and proteomics.

• Products: Molecular biology kits, cell analysis, and bioluminescence solutions.

• Market Cap: Private company (estimated revenue over USD 600 million).

11. Bruker Corporation

• About: Known for advanced analytical and structural biology tools.

• Products: Mass spectrometry, NMR, and imaging platforms.

• Market Cap: Approx. USD 9 billion.

12. GE Healthcare Life Sciences (Cytiva)

• About: Now operating under Cytiva, a part of Danaher.

• Products: Bioprocessing systems, chromatography, and cell therapy tools.

• Market Cap: Included in Danaher valuation.

13. Waters Corporation

• About: Specializes in liquid chromatography and mass spectrometry systems.

• Products: LC-MS, analytical chemistry tools, and software.

• Market Cap: Approx. USD 17 billion.

14. Illumina Inc.

• About: Dominates the genomics sequencing market with high-throughput systems.

• Products: NGS instruments, reagents, and data analysis tools.

• Market Cap: Approx. USD 25 billion.

15. 10x Genomics

• About: Specializes in single-cell and spatial genomics.

• Products: Chromium and Xenium platforms for cellular and spatial profiling.

• Market Cap: Approx. USD 4 billion.

16. Takara Bio

• About: A Japan-based company known for innovative biotech solutions.

• Products: Tools for gene editing, molecular biology, and regenerative medicine.

• Market Cap: Approx. USD 1.2 billion.

Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com

---

FAQs – Life Science Products Market

Q1. What are life science products?
Life science products include lab reagents, instruments, software, and consumables used in biological and medical research, diagnostics, and pharmaceutical manufacturing.

Q2. Which segment leads the market?
The reagents & consumables segment dominates with a 40% market share in 2024 due to frequent use in research and diagnostics.

Q3. What is driving the market growth?
Key drivers include increasing R&D in biotech and pharma, AI adoption in laboratories, and expanding applications in diagnostics.

Q4. Which region is expected to grow fastest?
Asia Pacific is expected to witness the fastest growth between 2025 and 2034, driven by investments in healthcare infrastructure and research.

Q5. Who are the major players in the life science products market?
Key companies include Thermo Fisher Scientific, Merck KGaA, Danaher, Qiagen, Illumina, and Agilent Technologies, among others.

Source : https://www.towardshealthcare.com/insights/life-science-products-market-sizing

Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5888